Sengenics | Precision Medicine Company |Videos

Antibody Profiling. Utility and Interpretation by Dr Janique Peyper

B Cell Repertoire in Determining Responses to Checkpoint Blockade in NSCLC by Prof. Middleton & Dr. Patel

Why does protein folding matter?

Origins & Utility of Autoantibodies in Oncology by Dr Janique Peyper

KREX Proteomic Analysis for Biomarker Discovery by Dr Geoff Dance

Discovering Novel Immunological Clues in Small Fiber Neuropathy with Innovative Techniques by Dr Amanda Chan

Advances in Precision Medicine in Lupus and Rheumatoid Arthritis by Dr Myles Lewis

The Human Immune System as a Source of Biomarkers by Dr Geoff Dance

Sengenics Corporate Overview

Sengenics KREX Technology for Biomarker Discovery, Patient Stratification and Companion Diagnostics

Sengenics p53 OncoREX Cancer Array Launch Seminar by Professor Jonathan Blackburn

SEROMAX Instruction Video

ImmuSAFE COVID+ Biochip Test

ImmuSAFE COVID+ Biochip Test for Vaccine Screening

ImmuSAFE COVID+ Biochip Test for Seroprevalence Studies

Ready to accelerate your program?

Let’s discuss your needs

Sengenics, a functional proteomics company, is committed to advancing precision medicine by empowering researchers with biologically relevant and actionable immunoproteomic insights across a broad spectrum of diseases. At the heart of its mission, Sengenics offers advanced, high-throughput tools using proprietary technology to precisely detect autoantibody biomarkers and protein interactions for basic, translational, and clinical research. Its robust tools have been leveraged by top pharmaceutical companies and leading research institutions to enhance disease understanding and streamline the biomarker pipeline.

Design and development by RainCastle Communications.

Explore our video library

Ready to accelerate your program?

Fill in the form to download the publication

Watch the video

Watch the video

Autoantibody-Based Diagnostic Biomarkers: Technological Approaches to Discovery and Validation

Read the Review

Watch the video